Neurovascular Guidewires Market Key Vendors, Current Trends by Manufacturers, Countries and Forecast To 2028 | Boston Scientific Corporation, B. Braun Melsungen AG, Smiths Group Plc. | FMI Report with Expert Review

Neurovascular guidewires are the metallic and non-metallic structures which guide the catheter through the blood vessels for the placement in the cardiology and radiology angiographic procedures. Neurovascular guidewires are used to treat aneurysms and cerebral arteriovenous abnormalities conditions by placing stent or coils in intracranial locations. The global demand for neurovascular guidewires will reach the valuation of nearly US$ 280 million in 2019, witnessing an estimated increase of 3.6% over 2018. Over 2018-2028, the global neurovascular guidewires market revenue is likely to expand 1.5X. Neurovascular guidewires market is projected to record a CAGR of 3.9% during the forecast period (2018-2028)

The global neurovascular guidewires market is driven by rise in prevalence of cardiovascular diseases, increase in number of interventional diagnostic procedures, surge in demand for minimally invasive surgeries, and favourable reimbursement scenario. However, high cost of minimally invasive surgeries and complications in guidewire usage are likely to hamper the growth of the global neurovascular guidewires market.

According to a new research study of Future Market Insights,

• Straight tip guidewires, with a current share of more than a third of the total market value, will retain the dominant position in neurovascular guidewires market through 2028.
• Aneurysms and intra-and extra-cranial angioplasty reflect highest applicability of neurovascular guidewires.
• Hospitals, though anticipated to reflect limited investment opportunities in the neurovascular guidewire market, will remain the leading end-use segment with the maximum share in terms of revenue generation.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-3121

The Increasing Number of Neurovascular Disease Treatment Alternatives

Neurovascular guidewires, among the latest innovations in the neurovascular disease treatment landscape, has been pushing the number of neurovascular surgeries since introduction. This according to the report will remain a key factor sustaining demand for neurovascular guidewires in the global market over the coming years.

As the advent of technology used in neurovascular surgeries has significantly increased the number of treatment options for neurovascular diseases, the treatment by using neurovascular guidewires is gaining ground rapidly owing to the relatively lower risk associated with surgical treatment, over conventional surgeries. The usage of guidewires is the mainstay for neurovascular therapy, along with new technologies such as coating-based guidewires, which has contributed substantially to the treatment options for complex lesions that are treated surgically.

The increasing number of neurovascular neuroradiology procedures is also boosting the demand for access products, which is another factor driving the neurovascular guidewires market. The number of neurovascular interventions is increasing with growing awareness among surgeons about the cost benefit associated with the neurovascular guidewires. Besides, reimbursement policies for outpatient surgeries are also expected to propel the neurovascular guidewires market revenue. Furthermore, an increase in the number of end users such as ambulatory surgical centers in underdeveloped and developing countries is boosting the number of outpatients cases, which is also expected to drive the overall market for neurovascular guidewires.

Preview analysis of Neurovascular guidewires market is segmented by (Product class – shapeable tip guidewiress, straight tip guidewiress, angled tip guidewiress & round curve tip guidewiress; Application – arteriovenous malformations, intracranial and extra-cranial angioplasty, aneurysms, minimally invasive spine surgery & cerebral angiography; Coating – hydrophilic guidewires & hydrophobic guidewires; End – User – hospitals, laboratories, research institutes, biopharmaceutical companies & others;): https://www.futuremarketinsights.com/reports/neurovascular-guidewires-market

Favorable Reimbursement Scenario & Government Support

The growing prevalence and incidence of cerebral infarction, aneurysm, and stroke is projected to fuel the demand for neurovascular guidewires. Growth in the number of patients suffering from ischemic stroke across the world is also estimated to boost the adoption of neurovascular guidewire and contribute to the growth of the global neurovascular guidewire market during the forecast period.

Similarly, increasing incidence of arteriovenous malformations is also contributing to growth in the demand for neurovascular guidewires. The increasing prevalence of intracranial and extracranial angioplasty is another factor that is expected to drive the neurovascular guidewires market.

Buy this report @ https://www.futuremarketinsights.com/checkout/3121

Neurovascular guidewires are effective and safe devices in neurovascular intervention procedures for patients suffering from neurovascular diseases. Modifications in reimbursement policies are encouraging the number of outpatients in developed countries. Government initiatives and local reimbursement policies pertaining to the usage of neurovascular guidewires are also expected to boost the neurovascular guidewire market over the forecast period.

Rising awareness about cerebral infarction is also estimated to contribute to the growth of the market. The reimbursement policies for the treatment of brain aneurysm are also contributing to the growth of the neurovascular guidewires market as the patients are not required to pay from their own pocket.

Some of the major market players in neurovascular guidewires market globally include Boston Scientific Corporation, B. Braun Melsungen AG, Smiths Group Plc., Terumo Corporation, Cook Medical, Inc., Medtronic, Inc., Asahi Intecc Co. Ltd., St. Jude Medical, Inc., Cordis Corporation and Abbott Laboratories..

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-3121

More from Healthcare, Pharmaceuticals and Medical devices Market Insights Market Intelligence:

• Metagenomics Analysis: Past and Future Trends – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018-2028
• Handheld Arthroscopic Instruments Market Analysis – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018-2028
• Handheld Arthroscopic Instruments Market Analysis – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018-2028

About us 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact us

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com